Noxopharm Limited announced the following senior appointments: Mr. Bhavin Raval has been appointed as Noxopharm Group Chief Financial Officer and Company Secretary (Nyrada); Dr. John Wilkinson has been appointed Noxopharm Chief Scientific Officer; Mr. James Bonnar has been appointed Vice-President, R&D (Nyrada); and Mr. Mark Waring has been appointed Senior Vice-President, US Operations (Nyrada).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 AUD | -10.26% | -12.50% | -1.41% |
May. 28 | Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7% | MT |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
1st Jan change | Capi. | |
---|---|---|
-1.41% | 15.03M | |
+49.21% | 56.87B | |
+36.16% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Limited Announces Management Appointments